Data / Form D filings / Polyamyna Nanotech Inc.
Polyamyna Nanotech Inc.: Form D filing
Polyamyna Nanotech Inc., a health care company in St. John'S, Newfoundland, Canada, filed a Form D with the SEC in 2023. The latest, on September 6, 2023, reports $353,921 sold of a $353,921 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 67 MAJOR'S PATH, UNIT 102, St. John'S, Newfoundland, Canada, A1A 4
- Phone
- (709) 315-3135
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Newfoundland, Canada
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1992526
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 6, 2023 | New notice | $353,921 | $353,921 | 1 | Sep 1, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ramesh Kumar Mani | Executive Officer, Director | |
| Bala Kishan Gorityala | Executive Officer, Director |
Every Form D from the week of Sep 4, 2023 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Polyamyna Nanotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.